As of January 22, 2025, Autolus Therapeutics (AUTL) has a market cap of $0.58 billion USD. According to our data, Autolus Therapeutics is ranked No.5935 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.58 B |
-7.45%
|
Dec 31, 2024 | $0.63 B |
-63.51%
|
Dec 29, 2023 | $1.71 B |
238.95%
|
Dec 30, 2022 | $0.51 B |
-63.39%
|
Dec 31, 2021 | $1.38 B |
-41.95%
|
Dec 31, 2020 | $2.38 B |
-32.27%
|
Dec 31, 2019 | $3.51 B |
-59.81%
|
Dec 31, 2018 | $8.74 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.77 B |
0.000 M
|
USA
|
bluebird bio
BLUE
|
$77.49 M |
-0.000 M
|
USA
|
Adaptimmune Therapeutics
ADAP
|
$0.14 B |
0.000 M
|
UK
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
USA
|
Intellia Therapeutics
NTLA
|
$1.12 B |
0.000 M
|
USA
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
0.000 M
|
USA
|
Allogene Therapeutics
ALLO
|
$0.40 B |
0.000 M
|
USA
|
Poseida Therapeutics
PSTX
|
$0.93 B |
0.000 M
|
USA
|
Iovance Biotherapeutics
IOVA
|
$1.83 B |
-0.000 M
|
USA
|
Atara Biotherapeutics
ATRA
|
$39.63 M |
0.000 M
|
USA
|
Market Cap | = | AUTL Stock Price | * | AUTL Shares Outstanding |
= | $2.17 | * | 0.27 B | |
= | $0.58 B |